| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |